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with NOAC at stroke onset were enrolled if informed consent by the patient or a legal representative was obtained.
Data Analysis
Neuroradiological images were analyzed by 2 readers. Consecutive follow-up images until day 7 were analyzed (details are given in online-only Data Supplement). 
Results
Twenty-eight patients were treated with thrombectomy alone (ET, n=23) or combined with IVT (IVT+ET, n=5).
Mean patient age was 74 years; 89% had an anterior circulation stroke (baseline characteristics are given in Table I in the online-only Data Supplement). Specific coagulation tests (available in 46%) indicated peak-range levels in 31% and trough-range in 69%. This was supported by unspecific coagulation tests (Table II in the online-only Data Supplement). For patients taking dabigatran, median activated partial thromboplastin time was not elevated, in contrast to the more sensitive thrombin time.
Procedural times are summarized in Table 1 . The start of catheter angiographies was not delayed by IVT. No bleeding complications were reported at the puncture site or airway.
sICH occurred only in 1 patient who had fatal procedural vessel perforation (Table 1) . Any ICH occurred in 46% of patients. In univariate analysis, no specific risk factor of sICH was identified (Table III in the online-only Data Supplement). Successful reperfusion (Thrombolysis in Cerebral Infarction score, 2b+3) was achieved in 59%, and 33% had partial reperfusion (Table 1) .
At 3 months, 19% of ET patients but none of the IVT+ET patients were independent (Table 2) , and 26% had died. In univariate analysis, previous ischemic stroke, male sex, and prestroke modified Rankin Scale score predicted unfavorable outcome (Table IV in the online-only Data Supplement).
Discussion
Our main finding is that thrombectomy in NOAC patients was not associated with an increased rate of sICH compared with data reported in nonanticoagulated patients.
sICH only occurred in a single patient with procedural vessel rupture. This low rate of sICH (4%) is consistent with recently reported aggregate data (3%) from cohorts of patients undergoing thrombolysis alone or combined with thrombectomy. 6 Forty-six percent of our patients experienced any hemorrhagic transformation. This proportion is comparable with a retrospective analysis in NOAC patients undergoing thrombectomy (53%) 7 but higher than that in patients on vitamin K antagonists (27%) 6 and the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands (MR CLEAN, 8%). 4 Although mortality was similar, less patients experienced a favorable outcome (modified Rankin Scale score, 0-2) at 3 months than in studies reporting on mixed thrombectomy and thrombolysis cohorts. 6, 7 Less favorable outcomes might have been caused by the lower reperfusion rates, [2] [3] [4] [5] 7, 8 longer symptom onset to intervention times, 9 higher age, 10 and more premorbid disability in our cohort. 10 Study limitations include the small sample size and the lack of a control group. Drug-specific coagulation tests indicated trough drug concentrations in the majority of patients (Table  II in the online-only Data Supplement), and correspondingly unspecific coagulation tests (international normalized ratio and activated partial thromboplastin time) were frequently within the normal range. Information on the safety of the procedure at peak drug levels is, therefore, limited.
In summary, thrombectomy in NOAC patients seems reasonably safe although a comparatively high rate of asymptomatic hemorrhagic transformation was noted. Confirmation of these results in larger controlled prospective cohorts is necessary.
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Imaging analysis
Neuroradiological images were analyzed independently by two experienced readers. Disagreement was resolved by consensus. Readers were blinded for patient details including the institution that had performed the intervention. Consecutive follow-up images until day 7 were analyzed; in case of rapid attenuation of initial hyperdensities on CT scans, this was categorized as contrast staining rather than hemorrhage. Catheter angiographies were analyzed to assess angiographic outcomes, including location of vessel occlusion, device and procedural complications, and reperfusion grade according to the modified Thrombolysis in Cerebral Infarction (TICI) score. 3 The time difference between start of catheter angiography and the first image showing any reperfusion of the previously occluded arterial segment represented the time to first reperfusion. The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) was calculated on parenchymal brain scans obtained before and after intervention. 4 In case of posterior circulation vessel occlusion, the posterior circulation ASPECTS (pc ASPECTS) was used. 5 Intraparenchymal hemorrhage was categorized into hemorrhagic infarction (HI1 and 2) and parenchymal hemorrhage (PH1 and 2) according to ECASS criteria. 6 Remote hemorrhage (PHr1 and 2) was defined as small or medium sized blood clots (PHr1) or large confluent dense blood clots (PHr2) in an area distant from the actual infarct.
Definitions of symptomatic intracranial hemorrhage (sICH)
SITS-MOST: sICH was diagnosed if local or remote PH2 on the scan obtained 22 to 36 hours after treatment plus neurologic deterioration as indicated by a score on the NIHSS that was higher by ≥ 4 points than the baseline value were observed. 7 ECASS-II defined sICH as blood at any site in the brain on the CT scan, documentation by the investigator of clinical deterioration, or adverse events indicating clinical worsening or causing a decrease in the NIHSS score of ≥ 4 points than the value at baseline or the lowest value in the first 7 d or any hemorrhage leading to death. 8 SWIFT-PRIME: sICH is defined as any PH, PHr, SAH, or intraventricular hemorrhage, associated with a ≥ 4 points worsening on the NIHSS within 24 hrs. 
Statistical Analysis
Categorical variables were reported as absolute and relative frequencies, continuous variables were described by mean and standard deviation (SD) or median and interquartilerange (IQR). Chi-square or Fishers-exact tests, as appropriate, were used to assess differences in baseline characteristics and radiological outcome between patients undergoing endovascular thrombectomy with or without preceding intravenous thrombolysis. Due to the skewness of the data, verified by Shapiro-Wilk test, non-parametric Mann-Whitney U test was used to compare continuous variables. Associations of demographic and clinical characteristics with aICH or unfavorable outcome (mRS4-6) at 3 month follow-up were measured using univariate logistic regression. Firth logistic regression was used if quasi-complete separation occurred and additionally the SAS-macro %fl was applied in order to estimate odds ratios and confidence intervals with penalized likelihood estimation methods and appendant penalized likelihood ratio tests. Because of the small sample size, no multivariable analyses were conducted. All analyses were performed using IBM SPSS Statistics, version 23 (IBM SPSS, Armonk, NY, USA) and SAS 9.3 (SAS Institute Inc., Cary, NC, USA) with p-values of <0.05 considered significant. 
